Nalaganje...

HER2/neu Immunostaining in Invasive Breast Cancer: Analysis of False Positive Factors

OBJECTIVES: HER2/neu gene amplification by Fluorescent in situ hybridization and protein expression by immunohistochemistry have been used for prognosis and guidance for the treatment of invasive ductal carcinoma of the breast with Trastuzumab. False positive results are a significant problem where...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Arafah, Maha, Kfoury, Hala K., Zaidi, Shaesta N.
Format: Artigo
Jezik:Inglês
Izdano: OMJ 2010
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3191663/
https://ncbi.nlm.nih.gov/pubmed/22043354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5001/omj.2010.78
Oznake: Označite
Brez oznak, prvi označite!